AUMANN AG INH O.N./ DE000A2DAM03 /
2024-05-15 8:11:20 AM | Chg. +1.2600 | Volume | Bid1:18:19 PM | Ask1:18:19 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
18.4400EUR | +7.33% | 228 Turnover: 4,204.3200 |
17.9600Bid Size: 60 | 18.1800Ask Size: 60 | 267.79 mill.EUR | 0.57% | - |
GlobeNewswire
1:32 PM
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
GlobeNewswire
1:30 PM
PDD Holdings to Report First Quarter 2024 Unaudited Financial Results on May 22, 2024
GlobeNewswire
1:30 PM
CORRECTION – Dragonfly Energy Reports First Quarter 2024 Financial and Operational Results
GlobeNewswire
1:30 PM
DeFi Technologies Subsidiary Valour Inc. Launches World's First Yield Bearing Bitcoin (BTC) ETP in C...
GlobeNewswire
1:30 PM
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with ...
GlobeNewswire
1:30 PM
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with To...
GlobeNewswire
1:30 PM
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
1:30 PM
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology...
GlobeNewswire
1:30 PM
AppTech Payments Corp. Reports Strong Start to 2024 with Positive First Quarter Financial Results an...
GlobeNewswire
1:30 PM
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress